Navigation Links
Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
Date:4/2/2008

Peter J. McGuire, MB BCh, of Mount Sinai Medical Center, New York was honored as the 2008-2009 recipient of the Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2008 Annual Clinical Genetics Meeting in Phoenix, AZ.

The objective of the Genzyme/ACMGF Award is to support a national fellowship program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. This award grants $75,000 per year and will provide for the sponsorship of a trainees first year of fellowship following residency in a genetics fellowship on biochemical genetic diseases.

The Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics is especially important at this point in history as we work together to increase the genetics workforce and to advance education, research and standards of practice in medical genetics in the United States. said R. Rodney Howell, MD, FACMG, president of the ACMGF.


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
2. UM coral scientist Peter Glynn wins award for scholarly activity
3. 12 McGill researchers awarded Canada Research Chairs
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. ETH Zurich professor Ari Helenius awarded Benoist Prize
6. Nanobiosym awarded $2 million DTRA contract
7. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
8. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
9. $2.7 million awarded for metastatic colon cancer research
10. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
11. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...on a previously unknown relationship between stem ...hondria a cell,s energy makers. Stem cells with mo...y to differentiate and are more likely to form tum...BC, could lead to methods of enriching the best st... may provide some insights into the role of stem c...
(Date:10/10/2008)...nvestigators from the Herman B Wells Center for Pe...of Medicine are focusing on a family of blood prot... toxic effects of chemotherapy in children and adu...evelopment of targeted therapies for leukemia, mul...The researchers, led by Kristin T. Chun, Ph.D., as...
(Date:10/10/2008)...Peninsula Medical School in Plymouth, UK, have car...derate exercise a day recommended to children from...sing problem of childhood obesity. , Their resea... the journal "Archives of Diseases in Childhood." ...ch has followed the development of over 200 childr...
(Date:10/10/2008)...ing the 1950s, Austrian and Swiss scientists condu...pal taking photographs of the glaciers, mountains ...ologist Fritz Mller spent eight months in the regi...otographing the Himalayan glaciers. , Now, fifty...n by these scientists are of immense value in tryi...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2Recommendations for children's exercise lacking say experts 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 1NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 2NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 3NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 4NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA Based Diagnostic Test for Melanoma 433 5China Technology Announces Entry to the Solar Energy Sector 431 1China Technology Announces Entry to the Solar Energy Sector 431 2China Technology Announces Entry to the Solar Energy Sector 431 3NuVasive to Host Investor Reception on September 11 2007 429 1NuVasive to Host Investor Reception on September 11 2007 429 2NuVasive to Host Investor Reception on September 11 2007 429 3NuVasive to Host Investor Reception on September 11 2007 429 4Microarray provides 3 genomic guides to breast cancer treatment decisions 750 1Microarray provides 3 genomic guides to breast cancer treatment decisions 750 2Microarray provides 3 genomic guides to breast cancer treatment decisions 750 3Microarray provides 3 genomic guides to breast cancer treatment decisions 750 4
...combination therapy drastically reduces the infect...ransplant patients with compromised immune systems... edition of Nature Medicine, originate from a stud...hodist Hospital, and Texas Children,s Hospital. ,...The phase 1 trial, funded by the National Heart, L...
...paint for a living may be placing their unborn chi...irth weight. , A study of construction workers in...ity of Alberta in Edmonton, Canada, links low birt...xposure to organic solvents such as paints, thinne...ry in its parent-reported assessment of birth outc...
...published study by investigators at the Center for...gno Rodríguez, MD, along with a nationwide team of...l thinking about the role of measurements of the a... predicting a patient,s ability to fight off the d...of JAMA (Journal of the American Medical Associati...
...ons in the receptor for a known inflammatory respo...isease and ulcerative colitis, according to a repo...chers in the October 26 online Science Express. , ...ly called inflammatory bowel disease (IBD), are ch...a and gastrointestinal bleeding and affect over on...
Other Biology News:Three-in-one virus killer prevents common, often fatal infections 2Solvent exposure linked to birth defects in babies of male painters 2AIDS study challenges conventional treatment guidelines for HIV patients 2AIDS study challenges conventional treatment guidelines for HIV patients 3Crohn's disease gene identified 2
(Date:10/9/2008)...o foot" dry adhesive got a new competitor this wee...rted in the journal Science by a team of researche...e long been interested in the ability of gecko liz...heir toes. The creatures owe this amazing ability...es that take advantage of atomic-scale attractive ...
(Date:10/9/2008)...ing Income Excluding Non-Cash Charges, SAN DIEGO,...Nasdaq:,CDIC), the innovator and leader of BioZ(R)...ported financial results for fiscal third quarter ...ompared with Third Quarter 2007 -- Net ICG sales ... -- International sales increased 35% to $690,000...
(Date:10/9/2008)...-FirstCall/ - Dr. Brad Thompson, President,and CEO...Y), will present a,corporate overview of the Compa...nce in London, U.K. on Monday, October 13 at 2 p.m...abeth II Conference Centre from October,12-14, 200... a Calgary-based biotechnology company focused on ...
(Date:10/9/2008)... 2009 to meet continued listing criteria, ROCHEST...Scopics, Inc.,(Nasdaq: VSCP ) today announced tha...y,s request to remain listed on the Nasdaq Capital... 3, 2009 to regain compliance with the,minimum bid...xtent of the,Panel,s authority to grant an excepti...
Breaking Biology Technology:Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 2Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 3Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 2CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 3CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 4CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 5CardioDynamics Reports Third Quarter 2008 Results, Seventh Consecutive Quarterly Revenue Growth and 15% Year to Date Revenue Increase 6Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2Nasdaq Grants VirtualScopics' Request for Continued Listing 2Nasdaq Grants VirtualScopics' Request for Continued Listing 3
...A silencing , products available from... the <A , href="http://www...., href="http://www.ambion.com/catalog/...on Kit . While this kit is very cost effective whe...es need to be made, it can be , advan...
...-PCR on Sympathetic Neuron Lysates , , Sile...lidated siRNAs , , ...Neuron Lysates , Quantitative RT-PCR i... for measuring mRNA levels from small numbers of c...an be difficult when cell samples are , ...
... siRNA , Construction Kit uses ... column purification to prepare transfect...it, multiple siRNAs can be prepared in ~24 hours. ...iRNAs prepared by the , Silenc... in gene silencing studies. , ...
..., Wollheim CB , (2004) Synaptot... Ca 2+ -dependent insulin exocytosis. J Cell ,... In a recently published paper in the ...i and colleagues used Ambions , ...ctor in , an extensive study to...
Other Biology Technology:Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA 2Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA 3YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 2YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 3YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 4YOUR DATA: , Direct Real-time RT-PCR on Sympathetic Neuron Lysates, , Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs 5Your Data: Silencing Hepatitis C Virus Replication With In Vitro Transcribed siRNAs 2Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 2Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 3Your Data: Use of pSilencer 1.0-U6 siRNA Expression Vector in the Analysis of Synaptotagmin Location and Function 4
...lity ISO 9001:2000 Certified USDA Research Regist... Validated, SOP's Training AALAS Certified Techn...res GLP Documentation Upon Request Focus CRP is ...mmunology service needs. We offer free project co...
Request Info
IC50: 190 pg/ml · Limit of detection: 60 pg/ml
Request Info
Biology Products: